-
Posted by
Two Blokes Wed at 7:30 PM -
Filed in
Stock
-
2 views
LifeMD is experiencing a major growth inflection, with record Q1 revenue, first-ever GAAP profitability, and strong subscriber and margin gains. Multiple growth drivers - including GLP-1 programs, Medicare expansion, AI automation, and a women's health acquisition - support a robust multi-year growth outlook. Valuation is high on earnings metrics but discounted on sales multiples. Significant upside exists if LifeMD sustains revenue growth and achieves positive EPS.
